EmVenio Research Expands in the UK

EmVenio Research, in collaboration with UK-based EMS Healthcare, will establish and operate commercial clinical trials in 10 mobile sites identified by EMS, across England, Wales, and Scotland. Each of the sites will be supported by a dedicated local workforce. EmVenio will be responsible for full clinical oversight, with principal and sub-investigators, and team leaders, and will oversee clinical trial operations and data management.

EmVenio currently operates research in 10 mobile community research sites across the United States.

Keith Austin, CEO of EMS Healthcare, said in press release, "A recent independent review of commercial clinical trials by Lord James O'Shaughnessy acknowledged the crucial role of mobile clinics in delivering trials with more diverse participation. We believe this initiative will attract more pharmaceutical sponsors to carry out trials, which will have a significant impact on both the U.K. economy and the health of our population."

Reference: EmVenio Research expands internationally with 10 research sites in the UK. DURHAM, N.C., June 20, 2023 /PRNewswire.